# pathway_0106

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **D** — tRNA modification

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MSLSLNEYLRYGRQLIVPEFGLQGQISLKNSRVLVVGAGGLGCPALQYLVGAGFGTVGIVDHDTVDISNLHRQILHTSETVEMLKCESAKLQLAKLNPLVQINTHPVALSPDNSFGIFEQYDIILDCTDTPATRYLINDTAVLLGLTVISGSGLKTEGQLSILNFNNTGPCYRCFYPTPPPPSSVTACSDGGVLGPVIGIMGVMMALEAIKVVSGYYLREDVEFQPFLSLYSGYGPLQSLRTFKMRRRSPKCRVCNAGTREITRHVIETELDYAVWCGKMDYNVLEKDERVSVEQLSAQRAPYLVDVRAKEQYSIVHLPNSINIPLNALKHMDTLDVPKETMIYVICRFGNDSQLAVKHLKSIGYENCVDVIGGLTQWSRQIDPNFPIY

[Multiple Choices]
A. L-valine from pyruvate: step 3/4. .
B. Alkaloid biosynthesis. .
C. IMP biosynthesis via de novo pathway
D. tRNA modification
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for UBA4, which annotates a role in tRNA modification and 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis. This supports choice D. The same protein is also annotated in molybdopterin biosynthesis, but that pathway is not among the choices. The tRNA-pathway annotation is curator-attributed rather than directly experimentally evidenced in the cited excerpt.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence alone does not provide a sufficiently specific, evident basis to identify its role in tRNA modification rather than the other listed pathways. Recognizing its function would require protein-specific knowledge.


**Missing item-specific fact**

> The protein-specific association of UBA4 with tRNA modification and thiolated tRNA biosynthesis.


**Reason**

> The matching annotation supports the key, but that reviewer-only information was not supplied to the evaluated model. General sequence-based reasoning does not meaningfully distinguish the pathway choice.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the listed options, the matched protein annotation supports D; the other annotated pathway, molybdopterin biosynthesis, is not offered.


### Important caveats

- The current and historical UniProt records match the supplied sequence, but the author's exact source snapshot is unknown.
- The tRNA-pathway annotation carries ECO:0000305, whereas the molybdopterin-biosynthesis annotation cites experimental evidence (ECO:0000269).

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence alone does not provide a sufficiently specific, evident basis to identify its role in tRNA modification rather than the other listed pathways. Recognizing its function would require protein-specific knowledge.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific association of UBA4 with tRNA modification and thiolated tRNA biosynthesis.",
    "reason": "The matching annotation supports the key, but that reviewer-only information was not supplied to the evaluated model. General sequence-based reasoning does not meaningfully distinguish the pathway choice."
  },
  "case_id": "pathway_0106",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "C6",
      "H3",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for UBA4, which annotates a role in tRNA modification and 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis. This supports choice D. The same protein is also annotated in molybdopterin biosynthesis, but that pathway is not among the choices. The tRNA-pathway annotation is curator-attributed rather than directly experimentally evidenced in the cited excerpt."
  },
  "important_caveats": [
    "The current and historical UniProt records match the supplied sequence, but the author's exact source snapshot is unknown.",
    "The tRNA-pathway annotation carries ECO:0000305, whereas the molybdopterin-biosynthesis annotation cites experimental evidence (ECO:0000269)."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed options, the matched protein annotation supports D; the other annotated pathway, molybdopterin biosynthesis, is not offered."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0106",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for UBA4, which annotates a role in tRNA modification and 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis. This supports choice D. The same protein is also annotated in molybdopterin biosynthesis, but that pathway is not among the choices. The tRNA-pathway annotation is curator-attributed rather than directly experimentally evidenced in the cited excerpt.",
    "evidence_ids": ["C1", "C5", "C6", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence alone does not provide a sufficiently specific, evident basis to identify its role in tRNA modification rather than the other listed pathways. Recognizing its function would require protein-specific knowledge.",
    "missing_item_specific_fact": "The protein-specific association of UBA4 with tRNA modification and thiolated tRNA biosynthesis.",
    "reason": "The matching annotation supports the key, but that reviewer-only information was not supplied to the evaluated model. General sequence-based reasoning does not meaningfully distinguish the pathway choice."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed options, the matched protein annotation supports D; the other annotated pathway, molybdopterin biosynthesis, is not offered."
  },
  "important_caveats": [
    "The current and historical UniProt records match the supplied sequence, but the author's exact source snapshot is unknown.",
    "The tRNA-pathway annotation carries ECO:0000305, whereas the molybdopterin-biosynthesis annotation cites experimental evidence (ECO:0000269)."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry W1QET1 (UBA4_OGAPD) explicitly lists 'tRNA modification; 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis' as a pathway (evidence C5/H3). Among the four choices, D is the only option matching any pathway annotation for this protein. However, the entry also lists 'Cofactor biosynthesis; molybdopterin biosynthesis' (C6/H4) with stronger experimental evidence (ECO:0000269 from PubMed:33617956), while the tRNA modification annotation carries only ECO:0000305 (inferred from electronic annotation). The protein's recommended name and EC numbers (2.7.7.80, 2.8.1.11) are for molybdopterin-synthase activities. Calling tRNA modification the 'primary' pathway is debatable, but since molybdopterin biosynthesis is not among the options, D is the only defensible match.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H4](#evidence-h4), [C4](#evidence-c4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a clear adenylyltransferase motif (GAGGLG, GFGTVG near N-terminus) combined with a thioredoxin-fold sulfurtransferase domain (CRFGNDSQ motif with catalytic cysteine). This adenylyltransferase + sulfurtransferase architecture is characteristic of the MnmA/ThiI/UBA4 family involved in tRNA thiolation pathways. It is inconsistent with: (A) valine biosynthesis (requires dihydroxy-acid dehydratase or transaminase domains), (B) alkaloid biosynthesis (requires P450s, specific methyltransferases, or terpene synthases), and (C) IMP de novo biosynthesis (requires GAR synthetase, AICAR synthetase, IMP cyclohydrolase, etc., none of which have sulfurtransferase domains). By elimination of A, B, and C through domain analysis, D is the most consistent choice.


**Missing item-specific fact**

> Distinguishing UBA4's tRNA modification role from its molybdopterin biosynthesis role (which has stronger experimental evidence) requires knowing the specific protein identity. However, since molybdopterin biosynthesis is not among the four options, this distinction is not needed to select the correct answer.


**Reason**

> The domain architecture (adenylyltransferase + sulfurtransferase) provides a concrete biological argument to eliminate options A, B, and C, which require entirely different enzyme classes. This makes D the only viable option through general enzymology reasoning, even without recognizing the exact UBA4 sequence.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the four choices, only D corresponds to any pathway annotation for this protein. Options A, B, and C are clearly inconsistent with the observed domain architecture. Although the protein also functions in molybdopterin biosynthesis (a stronger-evidenced pathway), that pathway is not offered as an option, so no ambiguity exists among the given choices.


### Important caveats

- The tRNA modification pathway annotation carries only ECO:0000305 (inferred from electronic annotation), the weakest evidence code, while the protein's primary enzymatic activities (EC 2.7.7.80, 2.8.1.11) are annotated for molybdopterin biosynthesis with experimental evidence (ECO:0000269).
- The question asks for the 'primary' pathway; calling tRNA modification 'primary' is questionable given the protein is literally named 'Molybdopterin-synthase adenylyltransferase/sulfurtransferase.' However, since molybdopterin biosynthesis is not an option, this does not affect answer selection.
- The adenylyltransferase + sulfurtransferase architecture is shared between UBA4/MOCS4 (molybdopterin biosynthesis) and MnmA/ThiI (direct tRNA thiolation); distinguishing these subfamilies from sequence alone is non-trivial, but both fall under 'tRNA modification' or 'cofactor biosynthesis' rather than the other three options.
- The UniProt entry was first public in June 2025; the author's source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a clear adenylyltransferase motif (GAGGLG, GFGTVG near N-terminus) combined with a thioredoxin-fold sulfurtransferase domain (CRFGNDSQ motif with catalytic cysteine). This adenylyltransferase + sulfurtransferase architecture is characteristic of the MnmA/ThiI/UBA4 family involved in tRNA thiolation pathways. It is inconsistent with: (A) valine biosynthesis (requires dihydroxy-acid dehydratase or transaminase domains), (B) alkaloid biosynthesis (requires P450s, specific methyltransferases, or terpene synthases), and (C) IMP de novo biosynthesis (requires GAR synthetase, AICAR synthetase, IMP cyclohydrolase, etc., none of which have sulfurtransferase domains). By elimination of A, B, and C through domain analysis, D is the most consistent choice.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Distinguishing UBA4's tRNA modification role from its molybdopterin biosynthesis role (which has stronger experimental evidence) requires knowing the specific protein identity. However, since molybdopterin biosynthesis is not among the four options, this distinction is not needed to select the correct answer.",
    "reason": "The domain architecture (adenylyltransferase + sulfurtransferase) provides a concrete biological argument to eliminate options A, B, and C, which require entirely different enzyme classes. This makes D the only viable option through general enzymology reasoning, even without recognizing the exact UBA4 sequence."
  },
  "case_id": "pathway_0106",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "H4",
      "C4"
    ],
    "judgment": "supported",
    "reason": "UniProt entry W1QET1 (UBA4_OGAPD) explicitly lists 'tRNA modification; 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis' as a pathway (evidence C5/H3). Among the four choices, D is the only option matching any pathway annotation for this protein. However, the entry also lists 'Cofactor biosynthesis; molybdopterin biosynthesis' (C6/H4) with stronger experimental evidence (ECO:0000269 from PubMed:33617956), while the tRNA modification annotation carries only ECO:0000305 (inferred from electronic annotation). The protein's recommended name and EC numbers (2.7.7.80, 2.8.1.11) are for molybdopterin-synthase activities. Calling tRNA modification the 'primary' pathway is debatable, but since molybdopterin biosynthesis is not among the options, D is the only defensible match."
  },
  "important_caveats": [
    "The tRNA modification pathway annotation carries only ECO:0000305 (inferred from electronic annotation), the weakest evidence code, while the protein's primary enzymatic activities (EC 2.7.7.80, 2.8.1.11) are annotated for molybdopterin biosynthesis with experimental evidence (ECO:0000269).",
    "The question asks for the 'primary' pathway; calling tRNA modification 'primary' is questionable given the protein is literally named 'Molybdopterin-synthase adenylyltransferase/sulfurtransferase.' However, since molybdopterin biosynthesis is not an option, this does not affect answer selection.",
    "The adenylyltransferase + sulfurtransferase architecture is shared between UBA4/MOCS4 (molybdopterin biosynthesis) and MnmA/ThiI (direct tRNA thiolation); distinguishing these subfamilies from sequence alone is non-trivial, but both fall under 'tRNA modification' or 'cofactor biosynthesis' rather than the other three options.",
    "The UniProt entry was first public in June 2025; the author's source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the four choices, only D corresponds to any pathway annotation for this protein. Options A, B, and C are clearly inconsistent with the observed domain architecture. Although the protein also functions in molybdopterin biosynthesis (a stronger-evidenced pathway), that pathway is not offered as an option, so no ambiguity exists among the given choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0106",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry W1QET1 (UBA4_OGAPD) explicitly lists 'tRNA modification; 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis' as a pathway (evidence C5/H3). Among the four choices, D is the only option matching any pathway annotation for this protein. However, the entry also lists 'Cofactor biosynthesis; molybdopterin biosynthesis' (C6/H4) with stronger experimental evidence (ECO:0000269 from PubMed:33617956), while the tRNA modification annotation carries only ECO:0000305 (inferred from electronic annotation). The protein's recommended name and EC numbers (2.7.7.80, 2.8.1.11) are for molybdopterin-synthase activities. Calling tRNA modification the 'primary' pathway is debatable, but since molybdopterin biosynthesis is not among the options, D is the only defensible match.",
    "evidence_ids": ["C5", "C6", "H3", "H4", "C4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a clear adenylyltransferase motif (GAGGLG, GFGTVG near N-terminus) combined with a thioredoxin-fold sulfurtransferase domain (CRFGNDSQ motif with catalytic cysteine). This adenylyltransferase + sulfurtransferase architecture is characteristic of the MnmA/ThiI/UBA4 family involved in tRNA thiolation pathways. It is inconsistent with: (A) valine biosynthesis (requires dihydroxy-acid dehydratase or transaminase domains), (B) alkaloid biosynthesis (requires P450s, specific methyltransferases, or terpene synthases), and (C) IMP de novo biosynthesis (requires GAR synthetase, AICAR synthetase, IMP cyclohydrolase, etc., none of which have sulfurtransferase domains). By elimination of A, B, and C through domain analysis, D is the most consistent choice.",
    "missing_item_specific_fact": "Distinguishing UBA4's tRNA modification role from its molybdopterin biosynthesis role (which has stronger experimental evidence) requires knowing the specific protein identity. However, since molybdopterin biosynthesis is not among the four options, this distinction is not needed to select the correct answer.",
    "reason": "The domain architecture (adenylyltransferase + sulfurtransferase) provides a concrete biological argument to eliminate options A, B, and C, which require entirely different enzyme classes. This makes D the only viable option through general enzymology reasoning, even without recognizing the exact UBA4 sequence."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the four choices, only D corresponds to any pathway annotation for this protein. Options A, B, and C are clearly inconsistent with the observed domain architecture. Although the protein also functions in molybdopterin biosynthesis (a stronger-evidenced pathway), that pathway is not offered as an option, so no ambiguity exists among the given choices."
  },
  "important_caveats": [
    "The tRNA modification pathway annotation carries only ECO:0000305 (inferred from electronic annotation), the weakest evidence code, while the protein's primary enzymatic activities (EC 2.7.7.80, 2.8.1.11) are annotated for molybdopterin biosynthesis with experimental evidence (ECO:0000269).",
    "The question asks for the 'primary' pathway; calling tRNA modification 'primary' is questionable given the protein is literally named 'Molybdopterin-synthase adenylyltransferase/sulfurtransferase.' However, since molybdopterin biosynthesis is not an option, this does not affect answer selection.",
    "The adenylyltransferase + sulfurtransferase architecture is shared between UBA4/MOCS4 (molybdopterin biosynthesis) and MnmA/ThiI (direct tRNA thiolation); distinguishing these subfamilies from sequence alone is non-trivial, but both fall under 'tRNA modification' or 'cofactor biosynthesis' rather than the other three options.",
    "The UniProt entry was first public in June 2025; the author's source snapshot is unknown."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `W1QET1` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 67. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/W1QET1.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:34:06.106793+00:00.  

```json
"W1QET1"
```

Source SHA-256: `958c25c940d458086b51fa46493ccb8538925f70cafe7242c4eeff6965bc6e08`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/W1QET1.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:34:06.106793+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Ubiquitin-like protein activator 4"}}],"includes":[{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Adenylyltransferase UBA4"}},{"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Sulfur carrier protein MOCS2A adenylyltransferase"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"O95396","source":"UniProtKB"}],"value":"2.7.7.80"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Molybdopterin-synthase adenylyltransferase"}}},{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Sulfur carrier protein MOCS2A sulfurtransferase"}},{"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Sulfurtransferase UBA4"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"O95396","source":"UniProtKB"}],"value":"2.8.1.11"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Molybdopterin-synthase sulfurtransferase"}}}],"recommendedName":{"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Adenylyltransferase and sulfurtransferase uba4"}}}
```

Source SHA-256: `958c25c940d458086b51fa46493ccb8538925f70cafe7242c4eeff6965bc6e08`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/W1QET1.json)  
**Locator:** `/comments/4`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:34:06.106793+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"tRNA modification; 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis"}]}
```

Source SHA-256: `958c25c940d458086b51fa46493ccb8538925f70cafe7242c4eeff6965bc6e08`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/W1QET1.json)  
**Locator:** `/comments/5`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:34:06.106793+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33617956","source":"PubMed"}],"value":"Cofactor biosynthesis; molybdopterin biosynthesis"}]}
```

Source SHA-256: `958c25c940d458086b51fa46493ccb8538925f70cafe7242c4eeff6965bc6e08`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/W1QET1?format=txt&versions=67)  
**Locator:** `lines 84-85`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 67 / 1.  
**Retrieved:** 2026-11-02T04:34:08.361822+00:00.  

```text
CC   -!- PATHWAY: tRNA modification; 5-methoxycarbonylmethyl-2-thiouridine-tRNA
CC       biosynthesis. {ECO:0000305}.
```

Source SHA-256: `1439891a4b0a62345927d6f7a896540071a99c07ab5153e3c7dc6126a8edc193`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/W1QET1?format=txt&versions=67)  
**Locator:** `lines 86-87`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 67 / 1.  
**Retrieved:** 2026-11-02T04:34:08.361822+00:00.  

```text
CC   -!- PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis.
CC       {ECO:0000269|PubMed:33617956}.
```

Source SHA-256: `1439891a4b0a62345927d6f7a896540071a99c07ab5153e3c7dc6126a8edc193`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 106. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
